Search Results for keywords:"National Institute on Drug Abuse"

The National Institute on Drug Abuse is holding a closed meeting to review grant applications as part of the NIDA Centers Grant Program. This meeting will take place virtually on May 2, 2025, from 10:30 a.m. to 4 p.m. The purpose of the meeting is to discuss confidential information, including trade secrets and personal details, which is why it will not be open to the public. Interested parties can contact Marisa Srivareerat, Ph.D., the Scientific Review Officer, for more information.

The National Institutes of Health has announced a change to the meeting schedule for the National Advisory Council on Drug Abuse. Originally planned to start at 11:00 a.m. on February 9, 2021, the closed session will now begin at 10:45 a.m. and end at 12:30 p.m. The meeting will take place at the National Institute on Drug Abuse in Bethesda, Maryland. Part of the meeting will be closed to the public.

The National Institute on Drug Abuse announced several upcoming closed meetings. These meetings will be held virtually and are scheduled to evaluate grant applications. Participants will review confidential information, including potential trade secrets and personal details about individuals involved in the grant applications. Contact persons for each specific meeting are provided for further inquiries.

The National Institute on Drug Abuse is holding closed meetings to discuss grant applications as part of the HEAL Initiative, which aims to translate research into practice to help end the overdose crisis. The meetings will take place virtually on May 1 and May 6, 2025, from 10:30 a.m. to 6:00 p.m. These discussions will remain private to protect confidential information and personal privacy. The meetings are organized by Sheila Pirooznia, Ph.D., a Scientific Review Officer at the National Institute on Drug Abuse.

The National Institute on Drug Abuse, part of the National Institutes of Health, announced several closed meetings to discuss and evaluate grant applications. These meetings, scheduled for February 2021, will be held virtually due to the confidential nature of the discussions, which may involve trade secrets and personal information. Committees will review applications related to HIV prevention, gene editing in marmosets, validating genes involved in substance use disorders, and NIDA Centers Review. As these are closed meetings, the public will not be able to attend.

The National Institute on Drug Abuse is holding a closed meeting to review and evaluate grant applications related to preventing the use of electronic nicotine delivery systems (ENDS) among adolescents. This meeting will take place on March 10, 2021, from 9:00 a.m. to 6:00 p.m., and will be held virtually at the National Institutes of Health. The sessions will be closed to the public due to the sensitivity of the content, which includes confidential information and personal data. Yvonne Owens Ferguson, Ph.D., is the contact person for more information.

The National Institute on Drug Abuse announced the cancellation of a Special Emphasis Panel meeting that was originally scheduled for April 3, 2025. The meeting was to take place at the National Institutes of Health in Bethesda, Maryland, but it will not be rescheduled. This cancellation was originally noted in the Federal Register on March 17, 2025.

The National Institute on Drug Abuse is holding several closed meetings in March 2021 to review and evaluate grant applications. These meetings are closed to the public to protect sensitive information, including trade secrets and personal privacy. They will be conducted virtually at the National Institutes of Health in Bethesda, MD. The meetings will cover various topics, including career development, using human cell animal chimera brains to study HIV, and studies on substance use prevention and treatment services.

The National Institutes of Health is holding a closed meeting for the National Institute on Drug Abuse Special Emphasis Panel on February 5, 2025. The meeting, which will be conducted virtually, aims to review and evaluate contract proposals related to the preparation and distribution of research drug products. The discussions are confidential and closed to the public to protect trade secrets and personal privacy. For additional information, individuals can contact Gagan Deep Bajaj, the Scientific Review Officer.

The National Institute on Drug Abuse has announced a meeting of the National Advisory Council on Drug Abuse scheduled for February 4, 2025. This meeting will occur virtually, with both open and closed sessions. The closed sessions, from 10:30 a.m. to 12:15 p.m., will involve the review of grant applications and a report from the Board of Scientific Counselors. The public can attend the open session from 1:00 p.m. to 5:00 p.m., which will include various presentations and council business, accessible through the NIH Videocasting and Podcasting website. Interested parties can submit comments to Dr. Gillian Acca in advance, and additional information is available on the respective websites.